Virtus ETF Advisers LLC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$66,393
-33.0%
9,954
-9.0%
0.04%
-32.2%
Q2 2023$99,107
-8.5%
10,939
-26.6%
0.06%
-1.7%
Q1 2023$108,338
-28.0%
14,902
-27.8%
0.06%
-24.1%
Q4 2022$150,385
+28.5%
20,629
+36.3%
0.08%
+68.1%
Q3 2022$117,000
+14.7%
15,135
+0.7%
0.05%
+23.7%
Q2 2022$102,00015,0290.04%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders